11 completed, 5 recruiting, 4 active not recruiting, 3 terminated. 9 Not applicable, 7 Phase 2, 3 Phase 1.
Follow Breast: new trials by email Literature Review of Breast trials Research Report on Breast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Topical Oxygen and LED Light Therapy on Nipple Crack Topical oxygen therapy, LED light therapy - Breastfeeding, Newborn Infant | Not applicable | Not yet recruiting | Istanbul University - Cerrahpasa | 51 | 2026-09-15 | 2026-05-27 |
| Physiotherapy After Breast Reduction Surgery Physiotherapy - Breast, Posture | Not applicable | Enrolling by invitation | Istanbul Rumeli University | 40 | 2026-07-23 | 2026-07-27 |
| Clinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by Artificial Intelligence Breast, Breast Cancer | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2000 | 2025-12-01 | 2026-03-03 | |
| Deep Optical Imaging of Tissue (DOIT) Mk1 - Healthy Tissue, Muscles | Not applicable | Recruiting | Lund University | 60 | 2025-11-25 | 2026-08-10 |
| A Bionic Breast Project Using Neuroprosthesis to Reduce Chronic Pain After Mastectomy Bionic Breast implant - Mastectomy, Breast | Not applicable | Recruiting | University of Chicago | 8 | 2025-05-14 | 2026-04-27 |
| A Multicenter Prospective Cohort Study of Adjuvant Therapy for BRCA1/2 Mutated Hormone Receptor-positive HER2-negative Early High-risk Breast Cancer Endocrine drug +CDK4/6 inhibitor or PRAP inhibitor or Endocrine drug +CDK4/6 inhibitor+PARP inhibitor - Breast | Enrolling by invitation | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 300 | 2025-01-19 | 2025-02-14 | |
| Measuring Electrical Properties of Breast Tissues WVI-MIS-01-2022 - Healthy, Breast | Not applicable | Completed | University of Calgary | 50 | 2024-05-27 | 2025-10-08 |
| A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast Cancer PLX038 - Breast, Cancer | Phase 2 | Terminated | Institut Curie | 14 | 2024-04-17 | 2026-01-02 |
| Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context Environmental health measures - Puberty, Precocious, Breast | Not applicable | Recruiting | Lille Catholic University | 62 | 2023-05-15 | 2026-03-17 |
| Robotic vs. Open NSM for Early Stage Breast Cancer Robotic NSM, Open NSM - Breast Cancer Female, Breast Cancer | Not applicable | Active not recruiting | Intuitive Surgical | 204 | 2023-05-08 | 2026-02-24 |
| Magnesium Sulphate Versus Ketamine as an Adjuvant to Bupivacaine in Pectoral Nerve Block During Mastectomy Use of Bupivacaine in pectoral nerve block in mastectomy, use of Ketamine as adjuvants to bupivacaine in pectoral nerve block in mastectomy, Use of Magnesium Sulfate as adjuvants to bupivacaine in pectoral nerve block in mastectomy - Cancer, Breast | Phase 2 | Completed | Beni-Suef University | 72 | 2022-12-01 | 2024-12-27 |
| Development of an Application-Based Digital Navigator for Perioperative Breast Surgery Patients JEEVA (new digital health navigator app) - Breast | Completed | M.D. Anderson Cancer Center | 60 | 2022-02-28 | 2025-10-14 | |
| A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation High Dose Vitamin D, Standard of Care Vitamin D - Breast, Breast Cancer | Not applicable | Completed | Wake Forest University Health Sciences | 7 | 2021-09-16 | 2025-07-23 |
| A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER) Capecitabine, Sarilumab 150mg or 200 mg plus Capecitabine, Sarilumab 150mg plus Capecitabine - Breast, Metastatic | Phase 1 / Phase 2 | Recruiting | University of Southern California | 65 | 2020-09-26 | 2026-03-10 |
| Breast Arterial Calcifications as an Imaging Biomarker of Cardiovascular Risk Mammography - Breast, Cardiovascular Calcification | Terminated | IRCCS Policlinico S. Donato | 149 | 2020-09-11 | 2025-09-04 | |
| Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer pegfilgrastim - Breast, Breast Cancer | Active not recruiting | Wake Forest University Health Sciences | 115 | 2019-12-17 | 2026-07-13 | |
| Case Collection Study to Determine the Accuracy, Call Back and Cancer Detection Rates of QT Ultrasound in Breast Imaging QT Ultrasound scan - Breast | Completed | QT Ultrasound LLC | 755 | 2017-04-18 | 2021-03-18 | |
| Detection of Breast Lesions by Automatic Breast US Ultrasonography, Breast | Unknown | Assuta Medical Center | 1200 | 2017-03-01 | 2017-03-21 | |
| Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy Palbociclib, Letrozole 2.5mg, Fulvestrant - Breast, Neoplasm Malignant | Completed | Istituti Clinici Scientifici Maugeri SpA | 191 | 2016-12-01 | 2020-08-24 | |
| A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. Olaparib, MEDI4736, Bevacizumab - Ovarian, Breast | Phase 1 / Phase 2 | Active not recruiting | AstraZeneca | 264 | 2016-03-17 | 2026-07-14 |
Showing 20 of 29. Sign in to see all of them.
Neoplasms (9) · Breast Neoplasms (7) · Neoplasm Metastasis (2) · Pain (2) · Agnosia (1) · Breast Diseases (1) · Breast Feeding (1) · Chronic Pain (1) · Lymphedema (1) · Osteoporosis (1) · Ovarian Neoplasms (1) · Pain, Postoperative (1) · Puberty, Precocious (1) · Sleep Initiation and Maintenance Disorders (1) · Small Cell Lung Carcinoma (1)
Neoplasms by Site (7) · Skin Diseases (7) · Skin and Connective Tissue Diseases (7) · Breast Diseases (6) · Neoplasms (6) · Pathological Conditions, Signs and Symptoms (6) · Neurologic Manifestations (4) · Signs and Symptoms (4) · Pathologic Processes (3) · Endocrine System Diseases (2) · Gonadal Disorders (2) · Neoplastic Processes (2) · Nervous System Diseases (2) · Pain (2) · Adnexal Diseases (1)
Hematologic Tests (2) · olaparib (2) · Bevacizumab (1) · Bupivacaine (1) · Capecitabine (1) · Carboplatin (1) · Drug Implants (1) · Fulvestrant (1) · Ketamine (1) · Letrozole (1) · Magnesium Sulfate (1) · Magnetic Resonance Spectroscopy (1) · Mammography (1) · Mastectomy (1) · Oxygen (1)
AstraZeneca (2) · National Cancer Institute (NCI) (2) · University of New Mexico (2) · Wake Forest University Health Sciences (2) · Assuta Medical Center (1) · Beni-Suef University (1) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Cedars-Sinai Medical Center (1) · First Affiliated Hospital of Zhejiang University (1) · IRCCS Policlinico S. Donato (1) · Institut Curie (1) · Intuitive Surgical (1) · Istanbul Rumeli University (1) · Istanbul University - Cerrahpasa (1) · Istituti Clinici Scientifici Maugeri SpA (1)
United States (15) · China (3) · France (3) · Israel (3) · Italy (2) · Sweden (2) · Turkey (Türkiye) (2) · Australia (1) · Canada (1) · Egypt (1) · Germany (1) · Netherlands (1) · South Korea (1) · Spain (1) · Switzerland (1)
Ian Rabinowitz, MD (2) · Anastasia Martynova, MD (1) · Arielle Heeke, MD (1) · Bella Kaufman, MD (1) · Christina Checka, MD (1) · Doaa M Khalil, lecturer (1) · James F. Cleary, M.B.B.S. (1) · Jane Robertson, BSc, MBCHB, MD (1) · Julie Fisher, MD (1) · Julio A Clavijo-Alvarez, MD (1) · Kevin A Camphausen, M.D. (1) · Madhu Gorrepati (1) · Michael L Gimbel, MD (1) · Raffaella Palumbo, MD, PhD (1)
PMID 10946929, PMID 11420508, PMID 22416063, PMID 25376971, PMID 26723501, PMID 26961146, PMID 32771088, PMID 35756843, PMID 37939124, PMID 42595593, PMID 7652060, PMID 9618094
2015 (1), P30CA012197 (1), R01CA238387 (1), R01CA281301 (1)